AI Sight Ltd is a company headquartered in the United Kingdom.
AI Sight Ltd develops AI-powered diabetic retinopathy screening technology that enables faster, accurate, and accessible eye disease detection to support early treatment and streamline healthcare workflows.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.